Precigen · 2 weeks ago
Associate Director Project Management CMC
Precigen is a biopharmaceutical company focused on advancing gene and cell therapies. The Associate Director will manage CMC focused project teams, develop integrated project plans, and ensure timely delivery of drug manufacturing projects by collaborating with various stakeholders.
BiotechnologyLife ScienceMedicalTherapeutics
Responsibilities
Manage and supervise CMC focused project teams
Define and communicate team roles and responsibilities, scope, goals and deliverables in collaboration with senior management and stakeholders
Develop and execute integrated project plans and information management practices
Regularly challenge timelines and offer innovative approaches to minimize risks to milestone delivery
Communicate project modifications to impacted parties with explanations of new responsibilities, deadlines, target dates, etc
Coordinate with members of the Legal and Finance departments to ensure concurrence with budgetary, intellectual property and other legal and fiduciary requirements
Develop and implement procedures for project monitoring to include team meetings, daily stand ups, individual action item follow-up, and meeting minutes
Manage workflow requirements and documentation related to the projects
Interface with executives/department leads for strategy and budgeting purposes
Manage External collaborations (CDMOs, CMOs, OTLs, etc.) and challenge delivery timelines of goods and services
Efficiently manage and maintain a system of problem resolution (i.e., change in project scope, requirements, deadlines, etc.)
Drive resolution of project conflicts by consulting with project teams and stakeholders in developing strategic and executable solutions
Provide weekly project reports
Serve as Operations representative on internal teams and focus groups including and not limited to Safety and Facilities Planning
Qualification
Required
B.S / M.S. in Science, Biological Engineering or Biotechnology
Five (5) + years of Manufacturing, CMC experience preferably Biologics
Five (5) to seven (7) years CMC project management experience, or combination of education and experience
Alliance Management with service providers (CMOs, CROs, research institutions, etc.)
Strong experience working with Pharma/Biotech on complex drug development programs
Mastery in technical scheduling, scenario planning and reporting from project management tools, such as Microsoft Project, or Smartsheet is a must
Excellent analytical thinker with exceptional planning, organization, and execution skills
Demonstrated ability to identify, prioritize and resolve key project and partnership issues
Ability to anticipate and solve problems while analyzing complex issues and environments
Strong attention to detail and excellence in project management, while effectively managing multiple projects/priorities
Strong oral and written communication skills and an ability to communicate complex concepts in a concise, simplified manner
Demonstrated ability to work with and coordinate demands from multiple internal and external stakeholders
Ability to effectively prioritize, reprioritize and execute in a high-pressure, milestone-driven, and rapidly changing environment is critical to the role
Exhibition of the highest degree of ethical standards and trustworthiness
Preferred
Program Management Professional (PgMP) or Project Management Professional (PMP®) certification desirable
Independent, enthusiastic and motivated to directly impact the manufacture of new life changing medicines for patients
Technical experience in drug manufacturing or engineering, as SME or CMC project manager
Agile, able to easily pivot to meet changing demands of the business
Excellent interpersonal skills with the ability to lead, focus, negotiate, resolve conflict and drive consensus across internal and external functions and levels
Company
Precigen
Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.
Funding
Current Stage
Public CompanyTotal Funding
$809.8MKey Investors
Pharmakon AdvisorsPatient Capital ManagementThird Security
2025-09-02Post Ipo Debt· $100M
2024-12-27Post Ipo Equity· $79M
2024-08-06Post Ipo Equity· $30M
Leadership Team
Recent News
2026-01-05
2025-11-15
Company data provided by crunchbase